Various mechanisms of resistance to EGFR-TKIs include alterations in downstream pathways (such as Akt mutations), and disruptions in apoptosis induced by EGFR-TKIs may contribute to the protective effects of SYN treatment in dogs with CIE. Here, EGFR is linked to congenital non-bullous ichthyosiform erythroderma.